Barclays PLC
10% owner at QVC Group; 10% owner at FrontView REIT; 10% owner at Launch One Acquisition.
- Rank
- 558th of 813
- Companies held
- 12
- Largest holding
- QVCG, 36.0% of total
- Latest SEC filing
- Aug 31, 2026
- Listed but not counted
- $177
What the $139M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| QVC Group QVCG Common Stock, par value, $0.01 per share | Barclays Capital Inc | 5,068,762 | $9.82 | $49.8M | 35.8% | Form 3, Aug 31, 2026 |
| Launch One Acquisition LPAA Class A ordinary shares, par value $0.0001 per share | Barclays Bank PLC | 2,455,000 | $11.05 | $27.1M | 19.5% | Form 3, Jul 17, 2024 |
| FrontView REIT FVR Common stock $0.01 par value per share | Barclays Bank PLC | 1,483,885 | $18.07 | $26.8M | 19.3% | Form 3, Oct 3, 2024 |
| Formula One FWONA Series A Liberty Braves Common Stock | Through Barclays Bank PLC | 111,368 split-adjusted | $102.39 | $11.4M | 8.2% | Form 3, Feb 16, 2022 |
| Formula One FWONA Series A Liberty Braves Common Stock | Through Barclays Capital Inc. | 108,773 split-adjusted | $102.39 | $11.1M | 8.0% | Form 3, Feb 16, 2022 |
| Pyxis Oncology PYXS Common Stock, par value $0.001 per share | Through Barclays Bank PLC | 3,477,945 | $1.68 | $5.8M | 4.2% | Form 3, Apr 25, 2022 |
| Zura Bio ZURA Class A Ordinary Shares, par value $0.0001 per share | Through Barclays Bank PLC | 2,340,240 | $0.95 | $2.2M | 1.6% | Form 3, Jan 9, 2023 |
| Borealis Foods BRLS Class A Ordinary Share, $0.0001 par value per share | Through Barclays Bank PLC | 1,929,405 | $0.70 | $1.4M | 1.0% | Form 3, Mar 9, 2022 |
| Minerva Neurosciences NERV Common Stock, $0.0001 par value per share | Through Barclays Bank PLC | 408,430 | $2.12 | $866K | 0.6% | Form 3, Aug 8, 2022 |
| Envoy Medical COCH Class A Ordinary Share, $0.0001 par value per share | Through Barclays Bank PLC | 87,749 split-adjusted | $6.70 | $588K | 0.4% | Form 3, Mar 6, 2023 |
| OmniAb OABI Common Stock, par value $0.0001 per share | Barclays Bank PLC | 106,904 | $5.03 | $538K | 0.4% | Form 3, Nov 4, 2022 |
| Minerva Neurosciences NERV Common Stock, $0.0001 par value per share | Through Barclays Capital Inc. | 196,800 | $2.12 | $417K | 0.3% | Form 3, Aug 8, 2022 |
| FrontView REIT FVR Common stock $0.01 par value per share | Barclays Capital INC | 21,319 | $18.07 | $385K | 0.3% | Form 3, Oct 3, 2024 |
| QVC Group QVCG Common Stock, par value, $0.01 per share | Barclays Bank PLC | 37,909 | $9.82 | $372K | 0.3% | Form 3, Aug 31, 2026 |
| OmniAb OABI Common Stock, par value $0.0001 per share | Barclays Capital Inc. | 27,440 | $5.03 | $138K | 0.1% | Form 3, Nov 4, 2022 |
| XBP Global Holdings XBP Class A common stock, par value $0.0001 per share | Through Barclays Bank PLC | 51,513 split-adjusted | $2.39 | $123K | 0.1% | Form 3, Feb 22, 2023 |
| Envoy Medical COCH Class A Ordinary Share, $0.0001 par value per share | Through Barclays Capital Inc. | 1,960 split-adjusted | $6.70 | $13K | 0.0% | Form 3, Mar 6, 2023 |
| AEON Biopharma AEON Class A common stock, par value $0.0001 per share | Through Barclays Bank PLC | 9,759 split-adjusted | $0.13 | $1K | 0.0% | Form 3, Feb 20, 2023 |
| Pyxis Oncology PYXS Common Stock, par value $0.001 per share | Through Barclays Capital Inc. | 30 | $1.68 | $50 | 0.0% | Form 3, Apr 25, 2022 |
Share counts are the amounts Barclays PLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Barclays PLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| MicroAlgo MLGO Ordinary shares, Par Value $.00001 Per Share | Through Barclays Bank PLC Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 103 split-adjusted | $1.72 | $177 | — | Form 3, Jul 11, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 555 | Richmond Hill Capital Management, LLC Insider, Reservoir Media | $139M |
| 556 | Richmond Hill Investment Co., LP Insider, Reservoir Media | $139M |
| 557 | Essex Equity Holdings, LLC Insider, Reservoir Media | $139M |
| 558 | Barclays PLC 10% owner, QVC Group | $139M |
| 559 | 325 Capital GP, LLC Insider, American Public Education | $138M |
| 560 | Suntx Capital Partners II Dutch Investors LP Director, Construction Partners | $138M |
| 561 | Averill Master Fund, Ltd. Director, Veradermics | $137M |
Questions
How much stock does Barclays PLC own?
Barclays PLC holds $139,108,998 in listed stock based on SEC filings and current prices, mostly QVC Group (QVCG). That ranks 558th on the Stock Rich List.
Is this Barclays PLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.